Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.
PLoS One
; 14(10): e0224203, 2019.
Article
in En
| MEDLINE
| ID: mdl-31644555
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
ABO Blood-Group System
/
Kidney Transplantation
/
Rituximab
/
Graft Rejection
/
Graft Survival
/
Isoantibodies
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2019
Document type:
Article
Affiliation country:
Japón